Search

everythinglearnresearchcommunity

for

Search:↓

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

No clear link between finasteride use and acute pancreatitis risk.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

People with more knowledge about their hair loss condition and those who see it as a serious issue are more likely to seek treatment.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Hair samples can be used to create stem cells easily and non-invasively.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

A woman developed rare, unexplained curly hair on her scalp and eyelashes.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.